Isaksen

TL3 Regular · Nice, FR

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 26 September 2024 · last posted 4h · groups: pharmacists

126 posts, newest first. Showing up to 150.

Mobile reading experience on long topics Replied, post #3 · Meta › Site feedback · 28 Jul 2026 · 5 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
Solubility limits and what a cloudy solution is telling you Replied, post #16 · Pharmacology › Formulation chemistry · 27 Jul 2026 · 3 likes Amino acid residues and formulation: the specific sequence and composition of a peptide affects what formulation conditions it tolerates. Sequences high in methionine…
Subgroup analyses: pre-specified versus discovered Replied, post #3 · Evidence › Trials · 27 Jul 2026 · 10 likes Worth separating two things that the opening post runs together. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #43 · Practice › Dosing & titration · 23 Jul 2026 · 18 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #60 · Clinical › Bloodwork · 23 Jul 2026 · 18 likes post #59 answers the question as asked. The question underneath it is different. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things.…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #51 · Access › Insurance & coverage · 21 Jul 2026 · 12 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
Insurance and replacement policies, compared Replied, post #97 · Sourcing › Logistics · 18 Jul 2026 · 32 likes Coming back to post #95, because the follow-up matters more than the original answer. Cold packs and temperature control: inclusion of cold packs at despatch is…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #123 · Evidence › Journal club · 17 Jul 2026 · 0 likes post #122 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Primary endpoint hierarchies and why order matters — one year on Replied, post #48 · Evidence › Trials · 16 Jul 2026 · 0 likes Worth separating two things that post #44 runs together. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it…
Common supplements people ask about, assessed one at a time Replied, post #42 · Practice › Interactions · 13 Jul 2026 · 3 likes post #41 answers the question as asked. The question underneath it is different. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #73 · Analytics › Impurities & related substances · 13 Jul 2026 · 18 likes Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
Follow-up: How compounding permissions changed when supply normalised Replied, post #14 · Sourcing › Regulatory · 12 Jul 2026 · 2 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
What I would want from a home test that does not exist yet — what changed since Replied, post #91 · Analytics › Home & field testing · 12 Jul 2026 · 22 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
Prior authorisation: what the criteria usually require — a second dataset Started this topic · Access › Insurance & coverage · 4 Jul 2026 · 0 likes Posting this under the heading it deserves: Prior authorisation: what the criteria usually require — a second dataset Everything below is what sits behind that. A…
Journal club: what we got wrong in an earlier session Replied, post #47 · Evidence › Journal club · 2 Jul 2026 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #13 · Evidence › Journal club · 1 Jul 2026 · 12 likes I read post #11 twice before replying, because I had assumed the opposite. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #50 · Analytics › HPLC & UHPLC · 27 Jun 2026 · 27 likes post #49 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Tracking a shortage from primary sources rather than rumour Replied, post #64 · Access › Shortages · 22 Jun 2026 · 12 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
Pooling trials with different estimands Replied, post #36 · Evidence › Meta-analyses · 20 Jun 2026 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #5 · Compounds › Retatrutide · 18 Jun 2026 · 14 likes Picking up post #2: that is the part I would want checked first. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted…
About the Receptor biology category Replied, post #4 · Pharmacology › Receptor biology · 18 Jun 2026 · 20 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #42 · Clinical › Comorbidities · 17 Jun 2026 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Pooling trials with different estimands Replied, post #29 · Evidence › Meta-analyses · 16 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #81 · Data & Tools › Datasets · 16 Jun 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #124 · Practice › Storage & stability · 10 Jun 2026 · 0 likes post #123 is right about the mechanism and I think understates the practical bit. I want to gently push back on the reply above about storage extrapolation. The advice…
Alcohol: what is documented and what is folklore Replied, post #44 · Practice › Interactions · 6 Jun 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #23 · Practice › Reconstitution · 5 Jun 2026 · 19 likes This follows post #20 rather than contradicting it. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic…
Second pass at: Programming during a large energy deficit Started this topic · Nutrition & Training › Resistance training · 23 May 2026 · 33 likes Posting this under the heading it deserves: Second pass at: Programming during a large energy deficit Everything below is what sits behind that. Longitudinal report…
Comparing documentation quality across the directory, tabulated Replied, post #3 · Sourcing › Vendor reports · 23 May 2026 · 17 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
Reading a trial's population section before its results Replied, post #40 · Evidence › Trials · 21 May 2026 · 22 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #21 · Evidence › Journal club · 16 May 2026 · 1 like post #20 is right about the mechanism and I think understates the practical bit. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0…
A single out-of-range value on an otherwise normal panel Replied, post #46 · Clinical › Bloodwork · 14 May 2026 · 5 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #18 · Evidence › Journal club · 12 May 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #91 · Clinical › Bloodwork · 3 May 2026 · 13 likes This follows post #88 rather than contradicting it. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening.…
The "under review" status pill and when a moderator applies it Replied, post #111 · Evidence › Preprints · 3 May 2026 · 7 likes Picking up post #108: that is the part I would want checked first. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted…
Transporting a vial for a weekend away — a second dataset Replied, post #41 · Practice › Storage & stability · 30 Apr 2026 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #56 · Practice › Reconstitution · 21 Apr 2026 · 1 like Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
[2026 update] Composite endpoints and the component doing the work Replied, post #77 · Evidence › Trials · 19 Apr 2026 · 2 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #33 · Outcomes › Progress reports · 18 Apr 2026 · 0 likes This follows post #30 rather than contradicting it. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the…
Sample handling between despatch and injection Replied, post #47 · Analytics › Method validation · 17 Apr 2026 · 0 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
List price versus negotiated price versus what you pay Replied, post #104 · Access › Pricing · 16 Apr 2026 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #80 · Practice › Interactions · 3 Apr 2026 · 0 likes post #79 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #11 · Evidence › Journal club · 19 Mar 2026 · 20 likes Picking up post #8: that is the part I would want checked first. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
Foaming during reconstitution and whether it matters — the long version Replied, post #65 · Practice › Reconstitution · 16 Mar 2026 · 7 likes Coming back to post #63, because the follow-up matters more than the original answer. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #5 · Compounds › Other compounds · 7 Mar 2026 · 20 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
The lowest dose that does anything: is that a real question? Replied, post #67 · Practice › Dosing & titration · 5 Mar 2026 · 7 likes This follows post #64 rather than contradicting it. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #13 · Research Methods › N-of-1 designs · 24 Feb 2026 · 13 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
Run-in periods and the population they select Replied, post #70 · Evidence › Trials · 21 Feb 2026 · 18 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #41 · Sourcing › Logistics · 19 Feb 2026 · 0 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #104 · Clinical › Special populations · 18 Feb 2026 · 0 likes Worth separating two things that post #100 runs together. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many…
Oral semaglutide bioavailability and its variability between people Replied, post #35 · Compounds › Oral incretins · 15 Feb 2026 · 11 likes Worth separating two things that post #31 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Follow-up: Reconciling a label claim with a content assay Replied, post #6 · Analytics › COA interpretation · 14 Feb 2026 · 12 likes post #5 answers the question as asked. The question underneath it is different. What fields matter on a certificate: lot number matching the vial, test date, the…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #34 · Analytics › Impurities & related substances · 14 Feb 2026 · 29 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Reading SURMOUNT-1 without the press release — one year on Replied, post #47 · Compounds › Tirzepatide · 14 Feb 2026 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #34 · Outcomes › Progress reports · 11 Feb 2026 · 27 likes post #33 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Pharmacy supply in the UK and the questions you will be asked Replied, post #30 · Regional › UK & Ireland · 4 Feb 2026 · 7 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #2 · Sourcing › Red flags · 1 Feb 2026 · 1 like Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #93 · Practice › Interactions · 19 Jan 2026 · 6 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #97 · Compounds › Semaglutide · 19 Jan 2026 · 4 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #8 · Clinical › Special populations · 6 Jan 2026 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical…
Second pass at: Metformin co-administration and additive GI effects Replied, post #21 · Practice › Interactions · 20 Dec 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Waist circumference technique and its repeatability Replied, post #27 · Outcomes › Progress reports · 15 Dec 2025 · 27 likes On post #23 — agreed on the reasoning, with one qualification. Medication changes: escalating dose, or adding or removing other medications, can affect the rate of…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #119 · Practice › Reconstitution · 13 Dec 2025 · 0 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
Tracking a preprint to publication: a worked example Replied, post #66 · Evidence › Preprints · 6 Dec 2025 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #35 · Sourcing › Regulatory · 25 Nov 2025 · 0 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
Research-use-only labelling: what it means and what it does not Replied, post #58 · Sourcing › Regulatory · 12 Nov 2025 · 5 likes post #57 is right about the mechanism and I think understates the practical bit. Primary documents matter: regulatory positions are published in official documents.…
Documentation that materially improves an appeal's chances Replied, post #59 · Access › Insurance & coverage · 11 Nov 2025 · 8 likes This follows post #56 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
What a purity-only report leaves out Replied, post #72 · Sourcing › Independent verification · 3 Nov 2025 · 13 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
EU-wide position versus national implementation — what changed since Replied, post #5 · Regional › European Union · 19 Oct 2025 · 2 likes Worth separating two things that the opening post runs together. Private prescription with self-payment is legal across the EU and is the common route where public…
History of disordered eating and why it changes the conversation Replied, post #17 · Clinical › Special populations · 13 Oct 2025 · 16 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
A parcel that arrived warm: a decision process, not a verdict Replied, post #74 · Practice › Storage & stability · 8 Oct 2025 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
The headache that turns out to be dehydration Replied, post #4 · Nutrition & Training › Hydration & electrolytes · 22 Sep 2025 · 0 likes Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
Managing an unplanned gap in supply — what changed since Replied, post #66 · Access › Shortages · 19 Sep 2025 · 1 like Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
Thyroid function tests during substantial weight change Replied, post #58 · Clinical › Bloodwork · 11 Sep 2025 · 14 likes post #57 is right about the mechanism and I think understates the practical bit. TSH and free hormones: TSH is a reasonable screening test but does not tell you about…
When a preprint is the best available evidence and we say so Replied, post #161 · Evidence › Preprints · 9 Sep 2025 · 15 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
Documentation that appears only after payment Replied, post #12 · Sourcing › Red flags · 26 Aug 2025 · 5 likes On post #8 — agreed on the reasoning, with one qualification. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating…
Follow-up: Why appetite effects are mostly central Replied, post #21 · Pharmacology › Receptor biology · 19 Aug 2025 · 0 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
A request that was declined, and the reasoning — a second dataset Replied, post #38 · Documentation › Wiki requests · 9 Aug 2025 · 5 likes On post #34 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
Hypertension improvement and when medication needs revisiting Replied, post #2 · Clinical › Comorbidities · 8 Aug 2025 · 10 likes the opening post is right about the mechanism and I think understates the practical bit. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not…
Are there stupid questions here? A staff answer, at length Replied, post #37 · Start Here › Welcome · 3 Aug 2025 · 1 like post #36 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #37 · Practice › Dosing & titration · 2 Aug 2025 · 26 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
A ten-fold dose error caught before injection — one year on Started this topic · Devices › Syringes & needles · 31 Jul 2025 · 4 likes On the subject in the title: A ten-fold dose error caught before injection — one year on Working notes rather than a conclusion. A question about technique rather than…
Canadian access and provincial variation — one year on Replied, post #48 · Regional › North America · 29 Jul 2025 · 15 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #85 · Evidence › Trials · 23 Jul 2025 · 21 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #20 · Compounds › Oral incretins · 22 Jul 2025 · 3 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
A field-by-field walk through a certificate of analysis Replied, post #19 · Analytics › COA interpretation · 14 Jul 2025 · 9 likes Coming back to post #17, because the follow-up matters more than the original answer. Sterility testing is separate: chromatographic purity, mass spectrometry, and…
Ipamorelin selectivity claims and where they came from Replied, post #53 · Compounds › Secretagogues & GH axis · 3 Jul 2025 · 0 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
Coming back to: What published stability data actually covers, and what it does not Replied, post #61 · Practice › Storage & stability · 11 Jun 2025 · 18 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #103 · Compounds › Tirzepatide · 6 Jun 2025 · 27 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #2 · Access › Insurance & coverage · 26 May 2025 · 26 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
DXA precision and the least significant change for lean mass — the long version Replied, post #75 · Outcomes › Body composition · 21 May 2025 · 14 likes Coming back to post #73, because the follow-up matters more than the original answer. Lean mass loss during rapid weight reduction: depends on protein intake,…
DXA precision and the least significant change for lean mass — the long version Replied, post #31 · Outcomes › Body composition · 12 May 2025 · 30 likes Coming back to post #29, because the follow-up matters more than the original answer. Resting metabolic rate: body composition affects metabolic rate. As fat mass…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #75 · Sourcing › Independent verification · 10 May 2025 · 31 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Follow-up: Requesting a page: what makes a good request Replied, post #28 · Documentation › Wiki requests · 30 Apr 2025 · 14 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion.
Validating a calculator against hand arithmetic — what changed since Replied, post #41 · Data & Tools › Calculators · 30 Apr 2025 · 8 likes post #40 answers the question as asked. The question underneath it is different. Dose equivalence calculator: compounds have different potencies. The calculator is…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 18 Apr 2025 · 1 like Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #29 · Evidence › Journal club · 18 Apr 2025 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Carryover and the ghost peak from last week's standard Replied, post #46 · Analytics › HPLC & UHPLC · 7 Apr 2025 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
Scheduled maintenance and what will be unavailable Replied, post #87 · Meta › Announcements · 27 Mar 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #18 · Sourcing › Vendor reports · 15 Mar 2025 · 0 likes On post #14 — agreed on the reasoning, with one qualification. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is…
Follow-up: Open-label extensions: what survives and what does not Replied, post #8 · marked as the solution · Evidence › Trials · 9 Mar 2025 · 18 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
Fibre intake when total intake falls, and the constipation link Replied, post #34 · Nutrition & Training › Protein & intake · 28 Feb 2025 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #2 · Evidence › Journal club · 18 Feb 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it…
How compounding permissions changed when supply normalised Replied, post #18 · Sourcing › Regulatory · 11 Feb 2025 · 3 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #92 · Evidence › Meta-analyses · 11 Feb 2025 · 13 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Coming back to: Preparing for an appointment: one page, three questions Replied, post #137 · Clinical › Prescriber conversations · 2 Jan 2025 · 0 likes Picking up post #134: that is the part I would want checked first. Asking about monitoring: understand what lab work will be done, how often, and what you will be…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #68 · Evidence › Journal club · 22 Dec 2024 · 23 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
A promotion I argued against, and why I lost Replied, post #27 · Documentation › Doc review · 11 Dec 2024 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Why "any advice?" is the least effective ending for a post Replied, post #89 · Start Here › How to Ask · 30 Nov 2024 · 2 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #22 · Nutrition & Training › Protein & intake · 26 Nov 2024 · 0 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #58 · Clinical › Prescriber conversations · 13 Nov 2024 · 3 likes post #57 answers the question as asked. The question underneath it is different. What to bring: copies of relevant lab results, pharmacy records (to confirm doses…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #112 · Analytics › COA interpretation · 10 Nov 2024 · 25 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
Revisiting: Moderation log format change Replied, post #16 · Meta › Announcements · 4 Nov 2024 · 15 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
Follow-up: Dead volume across syringe and needle combinations Replied, post #52 · Devices › Syringes & needles · 20 Oct 2024 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #9 · Clinical › Special populations · 15 Oct 2024 · 4 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #3 · Evidence › Journal club · 4 Oct 2024 · 1 like SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #33 · Sourcing › Independent verification · 3 Sep 2024 · 11 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #3 · Practice › Administration · 31 Aug 2024 · 32 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
How to ask for a dose change without antagonising anyone Replied, post #20 · Clinical › Prescriber conversations · 30 Aug 2024 · 0 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #29 · Evidence › Journal club · 29 Aug 2024 · 8 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
Signs of dehydration worth acting on Replied, post #5 · marked as the solution · Safety › Adverse events · 14 Aug 2024 · 31 likes Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported. FDA MedWatch in the US, Yellow Card in UK, EudraVigilance…
Promotion criteria, and the one that stops most nominations Replied, post #36 · Documentation › Doc review · 11 Aug 2024 · 10 likes Worth separating two things that post #32 runs together. Interdependencies: if updating one page requires updating related pages, posting that connection here helps the…
Oral contraceptives and delayed emptying: what the data shows Replied, post #37 · Practice › Interactions · 13 Jul 2024 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
The mass-error checker and its intended scope Replied, post #37 · Data & Tools › Calculators · 8 Jun 2024 · 16 likes post #36 is right about the mechanism and I think understates the practical bit. Reporting bugs: if you notice a calculator giving wrong results, report it in this…
Assessing a warm arrival: the decision process — one year on Replied, post #112 · Sourcing › Logistics · 1 Jun 2024 · 8 likes Picking up post #109: that is the part I would want checked first. Tracking stops updating: tracking last updated days ago usually means the package is in transit and…